Back to CAPITAL FUND MANAGEMENT S.A. CAPITAL FUND MANAGEMENT S.A.

ARWRARWR

Showing 6 of 24 quarters

Position history for CAPITAL FUND MANAGEMENT S.A.CAPITAL FUND MANAGEMENT S.A.'s holdings in ARROWHEAD PHARMACEUTICALS IN

No. Capital Fund Management exited its ARWR (Arrowhead Pharmaceuticals in) position in Q4 2025. Its Q3 2025 13F listed 35,140 shares worth $1.2M. Capital Fund Management first reported ARWR in Q1 2019 and held it in 18 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$793,860

Total Shares Change

-40,984

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$66.39
0
2025-Q3
Decreased
35,140
-84.5%
$1.2M0.0%$34.49
0
2025-Q2
Increased
226,365
+38.8%
$3.6M0.0%$15.80
35
2025-Q1
New
163,146
—
$2.1M0.0%$12.74
36
2024-Q4
Exited
0
-100.0%
$00.0%$18.80
0
2024-Q3
Increased
40,984
+10.4%
$793,8600.0%$19.37
27

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used